The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen

Lisanne En Manson; Cathelijne H van der Wouden; Jesse J Swen; Henk-Jan Guchelaar

doi:10.2217/pgs-2017-0093

The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen

Pharmacogenomics. 2017 Jul;18(11):1041-1045. doi: 10.2217/pgs-2017-0093. Epub 2017 Jul 7.

Authors

Lisanne En Manson¹, Cathelijne H van der Wouden¹, Jesse J Swen¹, Henk-Jan Guchelaar¹

Affiliation

¹ Department of Clinical Pharmacy & Toxicology, Leiden Network for Personalised Therapeutics, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands.

PMID: 28685652
DOI: 10.2217/pgs-2017-0093

No abstract available

Keywords: PREPARE study; U-PGx consortium; adverse drug reactions; block-randomized controlled trial; implementation; panel; pharmacogenomics; pre-emptive.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Europe
Humans
International Cooperation
Pharmacogenetics / methods*
Pharmacogenetics / trends
Pharmacogenomic Testing / methods*
Pharmacogenomic Testing / trends
Practice Guidelines as Topic
Precision Medicine / methods*
Precision Medicine / trends
Program Development*